MaaT Pharma Announces €18 Million Series B Financing Round
MaaT Pharma announced today an €18 million Series B financing round including a microbiome-focused US investor, SymBiosis, LLC, and support from its existing investors Seventure Partners, Crédit Mutuel Innovation, and Biocodex. The funding will enable … Continue reading MaaT Pharma Announces €18 Million Series B Financing Round
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed